OUR TEAM

Tomatis Pablo

Assistant Researcher, Associate Researcher

Dr. Pablo Emiliano Tomatis started his research training during his undergraduate thesis at the Institute of Investigations in Biotechnology in Buenos Aires Argentina. He graduated a Master in Biotechnology in 2000. Then in 2002 he started to work on directed molecular evolution of metallo-beta-lactamases as his PhD thesis project at the School of Biochemical and Pharmaceutical Sciences, University of Rosario, Argentina. He was awarded with several Postgraduate Research Fellowships to support his Ph.D. thesis work. In 2008 obtained his PhD degree Summa cum laude, and soon after he continued working as a postdoctoral fellow of the Argentinean National Research Council at the Institute of Molecular and Cell Biology of Rosario, Argentina. Since 2011 he is Assistant Researcher as Staff member of the Argentinean National Research Council, working on structural adaptability on protein evolution. From 2012 until the end of 2015, worked as postdoc at the University of Zürich, Switzerland, thanks to a Marie Curie International Incoming Fellowship and to Novartis Stiftung für medizinisch-biologische Forschung. After his postdoctoral training abroad, he returned to Argentina to work as an Assistant Researcher in the Metalloprotein Lab at the Institute of Molecular and Cell Biology of Rosario, Argentina. He Is also a Teaching Assistant in Biophysics, School of Biochemical and Pharmaceutical Sciences, University of Rosario (UNR). Dr. Tomatis is an active member of the MCAA Argentinian chapter.

linkedin.com/in/pabloemilianotomatis 

https://scholar.google.com/citations?hl=es&tzom=180&user=1PqeNAcAAAAJ

ORCID: 0000-0002-1126-8200

Twitter: @pabloetomatis

contacto@conicet.gov.ar

Sede CCT Rosario

Ocampo y Esmeralda, Predio CONICET-Rosario
2000 Rosario, Santa Fe, Argentina
Tel. 54-341-4237070 / 4237500 / 4237200

Sede Facultad de Ciencias Bioquímicas y Farmacéuticas

Universidad Nacional de Rosario - Suipacha 531
2000 Rosario, Santa Fe, Argentina
Tel. +54 341 4350596 / 4350661 / 4351235

🦠 Avance clave para hacer frente a infecciones polimicrobianas y multirresistentes.

Acinetobacter usa vesículas para desactivar antibióticos y resistir tratamientos. Este hallazgo abre nuevas vías para combatir infecciones difíciles. 🦠💊 👉 @lab_vila 👏